[email protected]

  • Follow
  • Follow
  • Follow
Crestone logo
  • Company
    • About Us
    • Team
    • Code of Ethics
    • Careers
    • Press Releases
  • Pipeline
    • CRS3123 for C. difficile
    • CRS0540 Gram-positives
    • CRS0393 NTM/TB
  • Knowledge Portal
  • Contact Us
Why are Gram negative Bacteria Harder to Kill due to Antibiotic resistance?

Why are Gram negative Bacteria Harder to Kill due to Antibiotic resistance?

by Crestone, Inc. | Sep 22, 2022 | Information

There are two main classifications of bacteria: Gram-positive and Gram-negative. Within each of the groupings, there are several types of bacteria. Antibiotic resistance in Gram-negative bacteria has been increasingly challenging for a few key reasons. Let’s...
What are Small Molecule Drugs and Why are they Effective? Insights from The Crestone, Inc. Colorado Biotechnology Company

What are Small Molecule Drugs and Why are they Effective?
Insights from The Crestone, Inc. Colorado Biotechnology Company

by Crestone, Inc. | Sep 15, 2022 | Information

Small-molecule agents make up the majority of medicines in use today. These are drugs that treat and prevent diseases by modulating biochemical processes. Examples of small-molecule drugs are aspirin and diphenhydramine, which are common in pharmaceutical cabinets....
Understanding Gram-Positive and Gram-Negative Bacteria Antibiotic Development

Understanding Gram-Positive and Gram-Negative Bacteria Antibiotic Development

by Crestone, Inc. | Aug 17, 2022 | Information

Understanding the difference between gram-positive and gram-negative bacteria is a crucial first step for diagnosing and treating bacterial infections. Both types of bacteria exist everywhere, but there are some key differences that set them apart. This article will...
Publication of Data on the Novel Antibiotic CRS0540

Publication of Data on the Novel Antibiotic CRS0540

by Crestone, Inc. | Aug 15, 2022 | Press Releases

Announcement Regarding CRS0540: Crestone, Inc. and Praedicare Inc. Announce the Publication of Data on the Novel Antibiotic CRS0540 in the Hollow Fiber System Model of the Orphan Disease Disseminated Listeriosis August 15, 2022—End-to-end drug development company...
What is Post-convalescence? Are There Signs of C. diff After Symptoms Have Improved?

What is Post-convalescence?
Are There Signs of C. diff After Symptoms Have Improved?

by Crestone, Inc. | Aug 4, 2022 | Information

What Causes C. difficile Infection? Every year, around 200,000 to half a million people in the United States become infected with C. difficile. However, the numbers have decreased in recent years because of increased prevention methods.C. difficile enters your body...
« Older Entries
Next Entries »

Copyright © Crestone, Inc. 2024. All Rights Reserved. Website by tekRESCUE